Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824. https://doi.org/10.1164/rccm.2009-040GL.

Article  PubMed  PubMed Central  Google Scholar 

Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795–806. https://doi.org/10.1183/09031936.00185114.

Article  PubMed  Google Scholar 

Ye Z, Hu Y. TGF–beta1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review). Int J Mol Med. Jul 2021;48(1). https://doi.org/10.3892/ijmm.2021.4965.

King TE Jr., Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949–61. https://doi.org/10.1016/S0140-6736(11)60052-4.

Article  PubMed  Google Scholar 

Zhou Y, Ling T, Shi W. Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis. Respir Res. 2024;25(1):245. https://doi.org/10.1186/s12931-024-02878-z.

Article  PubMed  PubMed Central  Google Scholar 

Richeldi L, et al. Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence. Eur Respir Rev. 2018. https://doi.org/10.1183/16000617.0074-2018.

Article  PubMed  PubMed Central  Google Scholar 

Rochwerg B, et al. Treatment of idiopathic pulmonary fibrosis: a network meta-analysis. BMC Med. 2016;14:18. https://doi.org/10.1186/s12916-016-0558-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lomeli-Nieto JA et al. Transforming growth factor beta isoforms and TGF-betaR1 and TGF-betaR2 expression in systemic sclerosis patients, Clin Exp Med, vol. 23, no. 2, pp. 471–481, Jun 2023, https://doi.org/10.1007/s10238-022-00841-0

Werner F, et al. Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem. 2000;275(47):36653–8. https://doi.org/10.1074/jbc.M004536200.

Article  CAS  PubMed  Google Scholar 

Qiu Y, et al. Application of recombinant TGF-β1 inhibitory peptide to alleviate isoproterenol-induced cardiac fibrosis. Appl Microbiol Biotechnol. 2023;107(20):6251–62. https://doi.org/10.1007/s00253-023-12722-x.

Article  CAS  PubMed  Google Scholar 

Ding H, Chen JJ, Qin JP, Chen RH, Yi ZL. TGF-β-induced α-SMA expression is mediated by C/EBPβ acetylation in human alveolar epithelial cells (vol 27, 22, 2021),. Mol Med. 2021;27(1):75. https://doi.org/10.1186/s10020-021-00340-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kapranov P, Willingham AT, Gingeras TR. Genome-wide transcription and the implications for genomic organization,. Nat Rev Genet. 2007;8(6):413–23. https://doi.org/10.1038/nrg2083.

Article  CAS  PubMed  Google Scholar 

Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics,. Nat Rev Genet. 2024;25(3):211–32. https://doi.org/10.1038/s41576-023-00662-1.

Article  CAS  PubMed  Google Scholar 

Uszczynska-Ratajczak B, Lagarde J, Frankish A, Guigo R, Johnson R. Towards a complete map of the human long non-coding RNA transcriptome,. Nat Rev Genet. 2018;19(9):535–48. https://doi.org/10.1038/s41576-018-0017-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Zhang Q, Zhou Y, Yang Z, Tan M. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-beta/Smad pathway,. Hum Exp Toxicol. 2020;39(5):683–95. https://doi.org/10.1177/0960327119895549.

Article  CAS  PubMed  Google Scholar 

Shen M, et al. Circ_0007535 upregulates TGFBR1 to promote pulmonary fibrosis in TGF-β1-treated lung fibroblasts via sequestering miR-18a-5p. Autoimmunity. 2023;56(1):2259128. https://doi.org/10.1080/08916934.2023.2259128.

Article  CAS  PubMed  Google Scholar 

Wang X et al. Jun., Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140, (in English). Mol Cell Biol, 39, 12, 2019, doi: ARTN e00143-1910.1128/MCB.00143 – 19.

O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation,. Front Endocrinol (Lausanne). 2018;9:402. https://doi.org/10.3389/fendo.2018.00402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bartel DP. Metazoan MicroRNAs,. Cell. 2018;173(1):20–51. https://doi.org/10.1016/j.cell.2018.03.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Lu FA, Wang L, Wang YF, Wu CF. Long non-coding RNA NEAT1 promotes pulmonary fibrosis by regulating the microRNA-455-3p/SMAD3 axis. Mol Med Rep. 2021;23(3):218. https://doi.org/10.3892/mmr.2021.11857.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023;42(38):2783–800. https://doi.org/10.1038/s41388-023-02780-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li HL, et al. FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis,. Int J Biol Sci. 2023;19(10):3042–56. https://doi.org/10.7150/ijbs.80140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C, et al. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation. J Biol Chem. 2017;292(40):16420–39. https://doi.org/10.1074/jbc.M117.805747.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parimon T, et al. Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles. JCI Insight. 2019;4(17):e129359. https://doi.org/10.1172/jci.insight.129359.

Article  Google Scholar 

Wei P, et al. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Cell Death Dis. 2019;10:670. https://doi.org/10.1038/s41419-019-1873-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu W, Yu N, Chen W, Zhu Y. ANRIL upregulates TGFBR1 to promote idiopathic pulmonary fibrosis in TGF-β1-treated lung fibroblasts via sequestering let-7d-5p. Epigenetics. 2024;19(1):2435682. https://doi.org/10.1080/15592294.2024.2435682.

Article  PubMed  PubMed Central  Google Scholar 

Yang LT, Liu X, Zhang N, Chen LF, Xu JY, Tang WC. Investigation of circular RNAs and related genes in pulmonary fibrosis based on bioinformatics analysis. J Cell Biochem. 2019;120(7):11022–32. https://doi.org/10.1002/jcb.28380.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao WX, et al. The CDR1as/miR-7/TGFBR2 axis modulates EMT in Silica-induced pulmonary fibrosis. Toxicol Sci. 2018;166(2):465–78. https://doi.org/10.1093/toxsci/kfy221.

Article  CAS  PubMed  Google Scholar 

Zhang Q, et al. miR-18a-5p inhibits sub-pleural pulmonary fibrosis by targeting TGF-β receptor II. Mol Ther. 2017;25(3):728–38. https://doi.org/10.1016/j.ymthe.2016.12.017.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang CL, Li XL, Zhang L, Cui DJ, Quan XJ, Yang WL. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis. Exp Mol Pathol. 2015;99(2):279–85. https://doi.org/10.1016/j.yexmp.2015.07.011.

Article